Market Overview

Intuitive Surgical Well-Positioned For Shift To Robotic Procedures, Piper Jaffray Says In Upgrade

Intuitive Surgical Well-Positioned For Shift To Robotic Procedures, Piper Jaffray Says In Upgrade

Robotic surgery device manufacturer Intuitive Surgical, Inc. (NASDAQ: ISRG) reports third-quarter earnings Oct. 18. Piper Jaffray outlined the results of a physician survey in an upgrade note issued ahead of the print. 

The Analyst

Analyst JP McKim upgraded Intuitive Surgical from Neutral to Overweight and raised the price target from $540 to $600.

The Thesis

Procedures such as general surgery and bariatric surgery will likely be completely different in the next five years — and Intuitive Surgical is best-positioned for the shift to robotic surgery, McKim said in the upgrade note. (See the analyst's track record here.) 

Piper Jaffray surveyed doctors practicing in specialties such as oncology, endocrinology, ophthalmology and cardiology on the adoption of robotic surgery.

“Both the physicians and moreso their patients view robotic surgery as better than traditional approaches. They expect robotic surgery in 10 years to penetrate half of the inpatient surgical procedures in the United States," the analyst said.

The doctors see bariatric, thyroid, gallbladder, colon, small bowel, hernia, and lung as being top applications for robotic procedures, with limited interest in pharynx, liver, heart, stomach and brain, McKim said. 

Intuitive Surgical's product upgrades this year have been strong and may demonstrate the early stages of an upgrade cycle, McKim said.

“Strategically, getting as many customers to the fourth-generation systems is prudent ahead of additional competition likely coming in 2020 from the larger players.”

Price Action

Intuitive Surgical shares were down 2.58 percent at $517.51 at the time of publication Wednesday. 

Related Links:

Analyst: Intuitive Surgical Is Moving Into Its 'Most Catalyst Rich' Cycle Ever

Intuitive Surgical Makes New All-Time High After Q3 Beat

Latest Ratings for ISRG

Dec 2020Morgan StanleyDowngradesOverweightEqual-Weight
Oct 2020SVB LeerinkMaintainsMarket Perform
Oct 2020Morgan StanleyMaintainsOverweight

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings


Related Articles (ISRG)

View Comments and Join the Discussion!

Posted-In: JP McKim Piper JaffrayAnalyst Color Upgrades Health Care Price Target Analyst Ratings General Best of Benzinga

Latest Ratings

URIVertical ResearchInitiates Coverage On310.0
PCARVertical ResearchInitiates Coverage On95.0
DEVertical ResearchInitiates Coverage On345.0
CNHIVertical ResearchInitiates Coverage On16.0
AGCOVertical ResearchInitiates Coverage On119.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at